Development
Gilead Sciences, Inc.
GILD
$112.46
-$2.05-1.79%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 1.43B | 2.18B | 1.05B | 1.01B | 1.64B |
| Total Depreciation and Amortization | 688.00M | 684.00M | 681.00M | 640.00M | 528.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 595.00M | 439.00M | 281.00M | 636.00M | 282.00M |
| Change in Net Operating Assets | -543.00M | -1.55B | 331.00M | -542.00M | 117.00M |
| Cash from Operations | 2.17B | 1.76B | 2.34B | 1.74B | 2.57B |
| Capital Expenditure | -215.00M | -122.00M | -139.00M | -109.00M | -181.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -279.00M | -79.00M | -243.00M | -551.00M | -218.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -233.00M | -28.00M | -101.00M | -166.00M | 24.00M |
| Cash from Investing | -727.00M | -229.00M | -483.00M | -826.00M | -375.00M |
| Total Debt Issued | 1.00M | 1.98B | -- | -- | -- |
| Total Debt Repaid | 0.00 | -2.25B | -- | -- | 0.00 |
| Issuance of Common Stock | 26.00M | 83.00M | 26.00M | 97.00M | 176.00M |
| Repurchase of Common Stock | -150.00M | -300.00M | -150.00M | -400.00M | -792.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -943.00M | -953.00M | -944.00M | -969.00M | -915.00M |
| Other Financing Activities | -33.00M | -78.00M | -33.00M | -134.00M | -23.00M |
| Cash from Financing | -1.10B | -1.52B | -1.10B | -1.41B | -1.55B |
| Foreign Exchange rate Adjustments | 37.00M | -6.00M | 13.00M | 13.00M | 75.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | 1.00M | -1.00M | -- |
| Net Change in Cash | 380.00M | 1.00M | 768.00M | -476.00M | 713.00M |